SB1043 would reduce Hawaii’s general excise tax rate on sales of nonprescription drugs by one-half. The bill adds a new section to chapter 237, Hawaii Revised Statutes, specifying that the tax rate on gross proceeds or gross income from the sale of over-the-counter medicines is 50 percent of the rate otherwise imposed under section 237-13(9). It defines “nonprescription drug” by reference to existing law in section 328-1.
The bill’s stated purpose is to ease the burden of Hawaii’s high cost of living, especially for working families and lower- and moderate-income residents, while stopping short of a full tax exemption that would reduce state revenue too much. The measure is framed as a targeted tax relief policy for essential health-related purchases rather than a broad tax cut. The bill, as amended in HD 1, is set to take effect on July 1, 3000, which appears to function as a placeholder or delayed effective date rather than a near-term implementation date.
Impact
If enacted, SB1043 would amend chapter 237, Hawaii’s general excise tax law, to create a reduced tax rate for nonprescription drugs. This would lower the tax burden on retailers and consumers purchasing over-the-counter medications, while also reducing state general excise tax revenue from those sales. The bill does not eliminate the tax entirely; it creates a partial exemption by cutting the applicable rate in half and leaves the existing tax structure otherwise intact.
Sentiment
The bill appears to have broad support in committee, passing the Senate Health and Human Services, Labor and Technology, and Ways and Means committees unanimously and advancing in the House without any recorded no votes. The discussion reflected a generally favorable view of targeted tax relief for essential goods, especially given Hawaii’s high cost of living. The absence of recorded opposition in the available votes suggests the measure was not highly controversial at the committee stage.
Contention
The main policy tension in the bill is between providing relief on essential consumer goods and preserving state revenue. The bill itself acknowledges that fully exempting groceries and nonprescription drugs from the general excise tax would better address regressivity, but that such a change would significantly reduce revenue needed for state fiscal needs. Any potential concern is therefore likely to center on the revenue loss from even a partial rate reduction, though the available vote history shows no recorded opposition in committee.
An Act to Require Health Insurance Coverage for Federally Approved Nonprescription Oral Hormonal Contraceptives and Nonprescription Emergency Contraceptives